Page 283 - DAS_Rehberi
P. 283

262                                                                  Kaynaklar


           KAPLICA HAVUZLARI VE FİZİK TEDAVİ HAVUZLARINDA TEMİZLİK VE DEZENFEKSİYON
           UYGULAMALARI
           1.  World Health Organization. Guidelines for safe recreational water environments. Volume 2 Swimming
              pools  and  similar  environments.  (https://www.who.int/publications/i/item/9241546808.  Erişim  tarihi:  1
              Temmuz 2024).
           2.  Centers for Disease Control and Prevention. Fecal Incident Response Recommendations for Aquatic Staff.
              2018. (https://www.cdc.gov/healthy-swimming/media/pdfs/fecal-incident-response-guidelines.pdf. Erişim
              tarihi: 1 Temmuz 2024).
           3.  Centers for Disease Control and Prevention. Water Contamınatıon Response Log.https://www.cdc.gov/
              healthy-swimming/media/pdfs/water-contamination-response-log-1.pdf Erişim tarihi: 1 Temmuz 2024)
           4.  Centers for Disease Control and Prevention. Body Fluid Contamination Response Log.https://www.cdc.
              gov/model-aquatic-health-code/php/about/index.html. Erişim tarihi: 1 Temmuz 2024)
           5.  Centers for Disease Control and Prevention. Operating Public Hot tubes. (https://phd5.idaho.gov/Docu-
              ments/Environmental-Health/Operating_Public_HotTubs_4-8-16.pdf. Erişim tarihi: 1 Temmuz 2024)
           6.  Centers for Disease Control and Prevention. Disinfection and testing. https://www.cdc.gov/healthywater/
              swimming/residential/disinfection-testing.html. Erişim tarihi: 1 Temmuz 2024)
           7.  U.S. Environmental Protection Agency (EPA) Disinfection Profiling and Benchmarking Guidance Manual.
              (https://www.epa.gov/system/files/documents/2022-02/disprof_bench_3rules_final_508.pdf. Erişim tarihi:
              1 Temmuz 2024)
           8.  Murphy JL, Arrowood MJ, Lu X, Hlavsa MC, Beach MJ, Hill VR. Effect of cyanuric acid on the inactivation
              of Cryptosporidium parvum under hyperchlorination conditions. Environ Sci Technol. 2015;49(12):7348-
              7355.

           PRİON HASTALIKLARINDA DAS UYGULAMALARI
           1.  Pritzkow S, Morales R, Lyon A, Concha-Marambio L, Urayama A, Soto C. Efficient prion disease trans-
              mission through common environmental materials. J Biol Chem. 2018;293(9):3363-3373.
           2.  Belay ED, Blase J, Sehulster LM, Maddox RA, Schonberger LB. Management of neurosurgical instruments
              and  patients  exposed  to  Creutzfeldt-Jakob  disease.  Infect  Control  Hosp  Epidemiol.  2013;34(12):1272-
              1280.
           3.  Sutton JM, Dickinson J, Walker JT, Raven ND. Methods to minimize the risks of Creutzfeldt-Jakob disease
              transmission by surgical procedures: where to set the standard?. Clin Infect Dis. 2006;43(6):757-764.
           4.  WHO tables on tissue infectivity distribution in transmissible spongiform encephalopathies. 2010. WHO/
              EMP/QSM/2010.1.  (https://www.who.int/publications/m/item/WHO-EMP-QSM-2010.1,  Erişim  Tarihi:
              05.07.2024)
           5.  Guıdelınes For Mınımısıng The Rısk of Contamınatıon of Transmıssıble Spongıform Encephalopathy (Tse)
              In Chınese Proprıetary Medıcınes, Health Supplements & Tradıtıonal Medıcınes. 2022. (https://www.hsa.
              gov.sg/docs/default-source/hprg-tmhs/tse-guidelines.pdf , Erişim Tarihi: 05.07.2024)
           6.  Secker TJ, Hervé RC, Keevil CW. Sensitive microscopic quantification of surface-bound prion infectivity
              for the assessment of surgical instrument decontamination procedures. J Hosp Infect. 2023;132:116-124.
           7.  Sakudo A. Inactivation Methods for Prions. Curr Issues Mol Biol. 2020;36:23-32.
           8.  Guidelines on Minimising the Risk of Transmission of Transmissible Spongiform Encephalopathies in
              Healthcare  Settings  in  Ireland  (2004)  https://www.hpsc.ie/az/microbiologyantimicrobialresistance/infec-
              tioncontrolandhai/guidelines/File,1193,en.PDF. Erişim Tarihi: 05.07.2024)
           9.  Prions. CDC. (https://www.cdc.gov/prions/about/index.html, Erişim Tarihi: 05.07.2024)
           10.  Altuna M, Ruiz I, Zelaya MV, Mendioroz M. Role of Biomarkers for the Diagnosis of Prion Diseases: A
              Narrative Review. Medicina (Kaunas). 2022;58(4):473.
           11.  Appleby BS, Shetty S, Elkasaby M. Genetic aspects of human prion diseases. Front Neurol. 2022;13:1003056.
           12.  Banerjee, P., Adhikary, K., Sarkar, R., Chakraborty, S., Jana, S. Prion diseases: A rare group of neurodegen-
              erative disorders. In book: Viral, Parasitic, Bacterial, and Fungal Infections Antimicrobial, Host Defense,
              and Therapeutic Strategies. First Edition, Elsevier: Academic Press, 2022, 651-662.
           13.  Booth CJ, Lichtenberg SS, Chappell RJ, Pedersen JA. Chemical Inactivation of Prions Is Altered by Bind-
              ing to the Soil Mineral Montmorillonite. ACS Infect Dis. 2021;7(4):859-870.
   278   279   280   281   282   283   284   285